Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS

Clinical trial NCT01300572 · COMPLETED

Trial details

NCT number: NCT01300572
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myelomonocytic Leukemia Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Secondary Acute Myeloid Leukemia

Start date: 2012-01-01
Primary completion: 2017-10-29
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.